Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GAMBIT Trial: A Randomized,Non-comparative, Open-label Clinical Trial Evaluating Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer

NCT01859728 is registered in ClinicalTrials.gov with Hospital de Cancer de Barretos - Fundacao Pio XII as lead sponsor.

NCT NCT01859728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01859728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GAMBIT Trial: A Randomized,Non-comparative, Open-label Clinical Trial Evaluating Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
Lead sponsor
Hospital de Cancer de Barretos - Fundacao Pio XII
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2013
Completion date
December 31, 2018
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary cancer